Skip to content
value.today

Allocortech Inc.

Total raised
$8 M
2 rounds on record
Latest round
$7 M
Jul 2026
First round on record
Oct 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Allocortech Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2026$7 MNo. 2$2 to $10 million

Allocortech Inc.: Raise no. 2, Jul 2026

Investors in this round

9 investors had bought by the notice of Sep 8, 2026: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Viele · Executive Officer, Director
  • Lee Chadwick Rogers · Executive Officer, Director
  • Matthew Walker · Executive Officer
  • Thomas Valentine · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lee Chadwick Rogers, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 8, 2026. Read the notice at the SEC.

equitySEC
Oct 2022$1 MNo. 1Under $2 million

Allocortech Inc.: Raise no. 1, Oct 2022

Investors in this round

1 investor had bought by the notice of Oct 21, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
$1,000,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Viele · Executive Officer, Director
  • Matt Walker · Executive Officer, Director
  • William Brown · Executive Officer
  • Justin Ritter · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Viele, Ceo. Source: SEC Form D, newest notice filed Oct 21, 2022. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Allocortech Inc. reported revenue of $2.39 million for its fiscal year to 28 April 2023 (filed Apr 2023), up from $1.64 million the year before.

    SEC Form C-AR · Apr 2023

  • The direct cost of what it sold was $330,247, so 86% of its revenue was left after those costs.

    SEC Form C-AR · Apr 2023

  • Net income for the same year: $85,640.

    SEC Form C-AR · Apr 2023

  • Allocortech Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2026).

    SEC Form D · Sep 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Sep 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Allocortech Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Allocortech Inc.
NameRoleNamed in
Brian VieleExecutive officerSep 2026
Lee Chadwick RogersExecutive officerSep 2026
Matthew WalkerExecutive officerSep 2026
Matt WalkerExecutive officerOct 2022
William BrownExecutive officerOct 2022
Brian VieleDirectorSep 2026
Lee Chadwick RogersDirectorSep 2026
Thomas ValentineDirectorSep 2026
Justin RitterDirectorOct 2022
Matt WalkerDirectorOct 2022